Figure 3
From: Engineered CHO cells as a novel AAV production platform for gene therapy delivery

Testing CHO-HVEM expressing clones for HVEM surface expression and rHSV-1-GFP infection. (a) Mean Fluorescence Intensity of the top 24 CHO-HVEM expressing clones. (b) Mean GFP expression from the final 24 clones post rHSV-1 GFP infection using the IncuCyte. Data from the mean GFP expression were analyzed using the Kruskal–Wallis test with Dunn’s multiple comparisons. Data (n = 2 per sample) presented as mean ± SD.